Analyst Updates: Changes for Thales, Safran, Kering...

Above their target: 8 stocks · SBF 120 covered stocks: 120

Stocks above their target: Teleperformance (-16.6%) · Eurofins Scientific (-14.0%) · Rémy Cointreau (-9.9%) · bioMérieux (-9.1%) · Worldline (-6.3%) · Dassault Systèmes (-6.1%) · Sodexo (-1.7%) · Euronext (-1.7%)

Safran: six brokers revise their target downward. Kepler Cheuvreux remains at buy and moves from 375 to 350 euros; BNP Paribas Wealth Management, now at "buy", goes from 350 to 325 euros; Goldman Sachs, at "buy", from 380 to 360 euros; Citi, still "neutral", from 345 to 310 euros; Morgan Stanley, on "in-line", from 373 to 316 euros; BofA Securities, at buy, from 432 to 409 euros. Seven analysts had lowered their targets over the past 10 days, last movement on October 26. Median at 350 euros, Target/Price gap: +29.2%.

From 1,540 to 1,406 euros: this is Citi's target on Hermès International, which maintains its "neutral" opinion. Six analysts had already lowered their targets, the last on October 23. The median of targets stands at 1,600 euros, Target/Price gap: +25.8%.

On Kering, Citi, still "neutral", reduces its target from 243 to 201 euros. Alphavalue is at "buy" with a target of 265 euros. Ten analysts had lowered their targets over the past 10 days, the last on October 23. Median at 240 euros, Target/Price gap: +35.8%.

Four adjustments are signed by Deutsche Bank. At bioMérieux, the target jumps from 75 to 103 euros, with an opinion upgraded from "hold" to "buy". A median of 82.50 euros places the consensus below the price: Target/Price gap: -9.1%. One analyst had raised his target on October 23. BE Semiconductor Industries sees its target move from 240 to 220 euros, with the opinion remaining at buy; six analysts had lowered their targets, the last on October 26. Median at 232.50 euros, Target/Price gap: +42.6%. Finally, Tikehau Capital moves from "buy" to "hold", target reduced from 21.50 to 18.50 euros. One analyst had lowered his target on October 26. Median at 19.40 euros, Target/Price gap: +21.4%.

Four stocks are revised by JP Morgan. Sodexo concentrates the upside revisions: JP Morgan, still on "overweight", moves from 68 to 70 euros; Barclays, on "market weight", from 54 to 60 euros; Deutsche Bank, on "hold", from 52 to 58 euros. Six analysts had raised their targets over the past 10 days, the last on October 26. Median at 58 euros, Target/Price gap: -1.7%. In the opposite direction, Saint-Gobain: JP Morgan, which remains on "overweight", goes from 95 to 93 euros, while Goldman Sachs, still "neutral", reduces its target from 85 to 76 euros. Two analysts had lowered their targets, the last on October 22. Median at 95 euros, Target/Price gap: +40.8%. On FDJ, JP Morgan remains on "underweight" and lowers its target from 19 to 18 euros; four analysts had lowered their targets, the last on October 26. Median at 24 euros, Target/Price gap: +15.3%. Finally, Worldline shares the movements: JP Morgan, "neutral", from 13.70 to 13.10 euros; BNP Paribas Exane, also "neutral", from 11 to 11.70 euros. Median at 11 euros, Target/Price gap: -6.3%.

At Schneider Electric, Jefferies, still at buy, raises its target from 323 to 329 euros, while CIC Market Solutions, also at buy, leaves its target at 325 euros. Two analysts had raised their targets and five had lowered them over the past 10 days, last movement on October 22. The median reaches 329 euros, Target/Price gap: +35%.

CIC Market Solutions publishes three targets today. TotalEnergies: target unchanged at 106.70 euros, "buy" opinion. Two analysts had raised their targets, the last on October 26. Median at 88 euros, Target/Price gap: +5.6%. BNP Paribas: 122 euros unchanged, "buy" opinion, median at 118.50 euros, Target/Price gap: +37%. Orange: CIC Market Solutions displays 17 euros, while Barclays, on "market weight", goes from 14.50 to 15 euros. One analyst had raised and another lowered his target, the last movement dating from October 20. Median at 19.70 euros, Target/Price gap: +37.9%.

From 5.50 to 4 euros: Stellantis suffers a sharp cut from Kepler Cheuvreux, which remains on "hold". One analyst had lowered his target on October 23. Median at 4.50 euros, Target/Price gap: +16.1%.

On Thales, Berenberg maintains its "hold" opinion and reduces its target from 275 to 260 euros. One analyst had lowered his target on October 23. Median at 287 euros, Target/Price gap: +22.3%.

Berenberg intervenes on four other stocks. At Valeo, the target moves from 15 to 14 euros, "buy" opinion maintained; two analysts had lowered their targets, the last on October 26. Median at 13 euros, Target/Price gap: +12.6%. Ipsos is adjusted from 72 to 70 euros, still at buy; two analysts had lowered their targets on October 26. Median at 47.50 euros, Target/Price gap: +32.3%. For Klepierre, Berenberg, at buy, reduces its target from 42 to 40 euros while JP Morgan, on "overweight", raises it from 39 to 40 euros. Median at 40 euros, Target/Price gap: +13.1%. Finally, Lisi: still at buy, Berenberg raises its target from 82 to 83 euros. One analyst had raised his target on October 23. Median at 75 euros, Target/Price gap: +18.3%.

BNP Paribas Wealth Management presents two contrasting views. Sartorius Stedim Biotech first: still at buy, the target climbs from 245 to 260 euros. Three analysts had raised their targets, the last on October 26. Median at 250 euros, Target/Price gap: +13.3%. Groupe SEB next, reduced from 80 to 75 euros with a "buy" opinion maintained; two analysts had lowered their targets on October 26. Median at 73.25 euros, Target/Price gap: +36.4%.

UBS adjusts four cases. EDP Renováveis: target reduced from 15 to 13.35 euros, "hold" opinion unchanged; two analysts had lowered their targets, the last on October 21. Median at 15.90 euros, Target/Price gap: +26.8%. Azelis moves from 12 to 12.50 euros, still on "hold"; median at 12.50 euros, Target/Price gap: +7.9%. EDP is raised from 5.20 to 5.40 euros, "buy" opinion maintained; median at 5.30 euros, Target/Price gap: +9.6%. Galp Energia, finally, goes from 25 to 24 euros, still at buy, for a median of 24 euros, Target/Price gap: +18%.

One line only for RELX: ING Wholesale remains at buy and raises its target from 45 to 46 euros. Median at 46 euros, Target/Price gap: +31%.

At Ayvens, ING Wholesale moves from "hold" to "buy" while reducing its target from 13.24 to 10 euros. Median at 10.80 euros, Target/Price gap: +23%.

From 1.10 to 0 delisting for Unibail-Rodamco-Westfield: Goldman Sachs, at buy, reduces its target from 124 to 121 euros. Median at 115 euros, Target/Price gap: +25.8%.

Two additional cases for Goldman Sachs. Valneva: the broker, on "sell", raises its target from 2.15 to 2.20 euros; median at 6.15 euros, Target/Price gap: +141.6%. GTT: "buy" opinion, target of 210 euros. One analyst had lowered his target on October 26. Median at 238 euros, Target/Price gap: +27.1%.

The UCB case brings together two upside movements: BofA Securities, still at buy, raises its target from 280 to 310 euros, and Alphavalue raises it from 260 to 267 euros, with a "reduce" opinion. Three analysts had raised and one lowered their targets over the past 10 days, last movement on October 23. Median at 270 euros, Target/Price gap: -0.4%.

For Edenred, Morgan Stanley, which remains on "overweight", adjusts its target from 35 to 34.50 euros. One analyst had raised and another lowered his target on October 22. Median at 33 euros, Target/Price gap: +36%.

At Randstad, Kepler Cheuvreux leaves its target at 37 euros. One analyst had raised his target on October 21. Median at 41.50 euros, Target/Price gap: +2.4%.

On Rémy Cointreau, TP Icap Midcap is at "sell" with a target of 39 euros, while Bernstein displays 53 euros, "market perform" opinion. Median at 43 euros, Target/Price gap: -9.9%.

On smaller stocks, The Navigator Company: JB Capital Markets moves from "neutral" to "buy", with a target of 4.20 euros. Median at 3.60 euros, Target/Price gap: +19%.

Broadpeak loses value in its target at Portzamparc: from 4.30 to 3.70 euros, "buy" opinion. Median at 3.70 euros, Target/Price gap: +113.9%.

Same movement for NFL Biosciences: Invest Securities, at buy, reduces its target from 2.30 to 1.70 euro. Median at 1.70 euro, Target/Price gap: +286.4%.

Greensome Finance publishes three targets. Unify Group: "buy" opinion, target unchanged at 6.60 euros; median at 4.30 euros, Target/Price gap: +145.7%. Memscap: "buy" opinion, target unchanged at 7.50 euros; median at 7.30 euros, Target/Price gap: +45.4%. Prologue: "buy" opinion, target of 41.87 euros.

Finally, Theraclion: TP Icap Midcap is at "buy", target 1.70 euro. Median at 1.70 euro, Target/Price gap: +161.5%.